Showing results (21-30 of 26) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 22, 2016
Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokineticsPamela Thompson, Ryan Fleming, Binyam Bezabeh, et al.Journal of Medicinal Chemistry|May 10, 2007
Rationally designed high-affinity 2-amino-6-halopurine heat shock protein 90 inhibitors that exhibit potent antitumor activitySrinivas R Kasibhatla, Kevin Hong, Marco A Biamonte, et al.Journal of Medicinal Chemistry|January 20, 2006
Orally active purine-based inhibitors of the heat shock protein 90Marco A Biamonte, Jiandong Shi, Kevin Hong, et al.Journal of Medicinal Chemistry|August 18, 2006
7'-substituted benzothiazolothio- and pyridinothiazolothio-purines as potent heat shock protein 90 inhibitorsLin Zhang, Junhua Fan, Khang Vu, et al.Molecular Cancer Therapeutics|September 25, 2023
A Novel Irreversible TEAD Inhibitor, SWTX-143, Blocks Hippo Pathway Transcriptional Output and Causes Tumor Regression in Preclinical Mesothelioma ModelsHanne Hillen, Aurélie Candi, Bart Vanderhoydonck, et al.Molecular Cancer Therapeutics|May 20, 2017
Preclinical Evaluation of MEDI0641, a Pyrrolobenzodiazepine-Conjugated Antibody-Drug Conjugate Targeting 5T4Jay Harper, Christopher Lloyd, Nazzareno Dimasi, et al.Pageof 3